SCHEMBL185837

SCHEMBL185837

COc1cccc2c1c(N)nn2C(=O)OCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
P2RX4 Q99571 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.37
GAA P10253 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
PLA2G2A P14555 3/20 0.35
TSHR P16473 1/20 0.35
DCPS Q96C86 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185525 0.81 ALDH1A1 (0.38) ALDH1A1KDM4EMEN1KMT2AP2RX4
SCHEMBL186237 0.80 MAP2K4 (0.41) BRD4ALDH1A1KDM4EMAPTGAA
SCHEMBL186109 0.74 CCR4 (0.62)
SCHEMBL1855369 0.70 SCN9A (0.45) ALDH1A1MEN1KMT2AP2RX4NPC1
SCHEMBL18953224 0.70 ELANE (0.56) ALDH1A1P2RX4SCN9A
SCHEMBL15995815 0.70 KCNA5 (0.51) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL11752156 0.69 F2 (0.40) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL17311564 0.68 ELANE (0.50) P2RX4
SCHEMBL11747221 0.68 MAP2K4 (0.44) GAASMN1; SMN2SCN9A
SCHEMBL2302376 0.67 ELANE (0.39) KDM4EMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401270-A1 PYRAZOLE DERIVATIVES USED AS CCR4 RECEPTOR ANTAGONISTS Glaxo Group Limited (GB) 2012-01-04 EP disclosed
WO-2010097395-A1 PYRAZOLE DERIVATIVES USED AS CCR4 RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2010-09-02 WO disclosed